ReoPro and peripheral arterial intervention to improve clinical outcome in patients with peripheral arterial disease – a randomized prospective trial (RIO-Trial)

Trial Profile

ReoPro and peripheral arterial intervention to improve clinical outcome in patients with peripheral arterial disease – a randomized prospective trial (RIO-Trial)

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Abciximab (Primary)
  • Indications Death; Embolism and thrombosis; Peripheral arterial occlusive disorders
  • Focus Therapeutic Use
  • Acronyms RIO
  • Most Recent Events

    • 02 Oct 2006 Status change
    • 31 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top